Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Christopher Kane

Clinical trials sponsored by Christopher Kane, explained in plain language.

Immune drug rituximab tested to shrink prostate tumors before surgery

Disease control Completed

This early-phase trial tested whether rituximab, a drug that depletes B cells, could reduce immune cell infiltration in prostate tumors. Eight high-risk prostate cancer patients received four weekly doses before their scheduled prostate removal. The main goal was to see if B-cell…

Early phase 1 • Sponsor: Christopher Kane • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC